XML 59 R47.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Oct. 01, 2017
Jul. 02, 2017
Oct. 02, 2016
Oct. 01, 2017
Oct. 02, 2016
Segment Reporting Information [Line Items]          
Percentage Change in Operating Income Loss (9.30%)     (2.40%)  
Royalty Revenue, Monetization of Royalty $ 200        
Restructuring charges 69   $ 62 $ 165 $ 296
Asset write-downs       309 187
Pharmaceutical          
Segment Reporting Information [Line Items]          
Valuation Allowances and Reserves, Additions for Adjustments       500  
Royalty Revenue, Monetization of Royalty       200  
Gain on sale of equity investments       300 200
Medical Devices          
Segment Reporting Information [Line Items]          
Restructuring charges 200   100 500 400
Litigation Expense 100   100 500 700
Asset write-downs   $ 200   200  
Operating Segments [Member]          
Segment Reporting Information [Line Items]          
Total Segment Operating Income $ 5,118   5,514 $ 16,004 16,197
Percentage Change in Operating Income Loss (7.20%)     (1.20%)  
Operating Segments [Member] | Consumer          
Segment Reporting Information [Line Items]          
Total Segment Operating Income $ 878   679 $ 2,132 1,816
Percentage Change in Operating Income Loss 29.30%     17.40%  
Operating Segments [Member] | Pharmaceutical          
Segment Reporting Information [Line Items]          
Total Segment Operating Income $ 2,857   3,309 $ 9,934 10,340
Percentage Change in Operating Income Loss (13.70%)     (3.90%)  
Operating Segments [Member] | Medical Devices          
Segment Reporting Information [Line Items]          
Total Segment Operating Income $ 1,383   1,526 $ 3,938 4,041
Percentage Change in Operating Income Loss (9.40%)     (2.50%)  
Corporate, Non-Segment [Member]          
Segment Reporting Information [Line Items]          
Total Segment Operating Income $ 328   $ 233 $ 891 $ 718
Actelion [Member]          
Segment Reporting Information [Line Items]          
Business Combination, Acquisition Related Costs 400     600  
Actelion [Member] | Pharmaceutical          
Segment Reporting Information [Line Items]          
Business Combination, Acquisition Related Costs 400     600  
Compeed [Member] | Discontinued Operations, Disposed of by Sale [Member]          
Segment Reporting Information [Line Items]          
Gain on divestiture $ 400     $ 400